Product image of Orfiril Retard (Sodium Valproate) supplied by GNH India

Orfiril Retard

Active Ingredient:
Sodium Valproate
Origin:
EU

Orfiril Retard (Sodium Valproate)

Sodium Valproate, the active ingredient in Orfiril Retard, is an anticonvulsant presented as an extended‑release tablet for oral use. It treats generalized and focal seizures, stabilises mood in bipolar disorder and is used for migraine prophylaxis in adults. GNH India supplies Orfiril Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH India supplies Orfiril Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Desitin Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Orfiril Retard is an antiepileptic medication that acts on neuronal excitability in several neurological and psychiatric conditions.

  • Epilepsy: Reduces the frequency and severity of generalized and focal seizures.
  • Bipolar disorder: Provides mood stabilization and helps prevent manic episodes.
  • Migraine prophylaxis: Decreases the number of migraine attacks when used as preventive therapy.

How It Works

  • Sodium valproate increases gamma‑aminobutyric acid (GGABA) concentrations in the brain by inhibiting its degradation and enhances GABA‑mediated neuronal inhibition. It also blocks voltage‑gated sodium channels, stabilising neuronal membranes and reducing the rapid firing of neurons that underlies seizure activity and mood dysregulation.

Side Effects

Adverse reactions to Orfiril Retard vary in frequency and severity.

Common Side Effects

  • Nausea and vomiting
  • Tremor
  • Weight gain
  • Hair loss
  • Drowsiness
  • Elevated liver enzymes

Serious or Rare Side Effects

  • Severe liver injury
  • Pancreatitis
  • Thrombocytopenia
  • Hyperammonemia
  • Stevens‑Johnson syndrome
  • Fatal brain edema

Precautions & Warnings

When prescribing Orfiril Retard, clinicians should consider several safety aspects.

  • Monitor liver function: Regular blood tests are required to detect hepatotoxicity.
  • Assess blood counts: Periodic complete‑blood‑count monitoring helps identify thrombocytopenia.
  • Evaluate pancreatic enzymes: Check amylase and lipase if abdominal symptoms arise.
  • Review psychiatric history: Monitor for mood changes or depressive symptoms.
  • Avoid use in pregnancy: Contra‑indicated due to teratogenic risk (Category X).
  • Store at below 25°C: keep in the original packaging, protect from moisture and light.

Avoid Interactions

Orfiril Retard can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

  • Carbamazepine: Increases valproate clearance, reducing efficacy.
  • Phenytoin: Reduces valproate plasma levels and may precipitate seizures.
  • Rifampicin: Strong enzyme inducer that markedly lowers valproate concentrations.

Moderate Interactions (Monitor Closely)

  • Warfarin: Valproate may enhance anticoagulant effect, requiring INR monitoring.
  • Oral contraceptives: May reduce hormonal efficacy, increasing risk of breakthrough bleeding.
  • Lamotrigine: Valproate raises lamotrigine levels, heightening risk of skin reactions.

Frequently Asked Questions

Orfiril Retard is prescribed for the management of generalized and focal seizures in epilepsy, as a mood‑stabilising agent in bipolar disorder, and for preventive treatment of migraine headaches in adults.

Sodium valproate raises brain levels of the inhibitory neurotransmitter GABA by blocking its breakdown and also stabilises neuronal membranes by inhibiting voltage‑gated sodium channels, which together reduce excessive neuronal firing.

The dose of Orfiril Retard is individualized; a prescriber determines the appropriate strength and titration schedule based on the patient’s condition, age, weight and response to therapy.

Sodium valproate is classified as pregnancy Category X because it carries a high risk of birth defects and developmental disorders; it is contraindicated in pregnancy and generally avoided during breastfeeding.

To order, submit an enquiry on the Orfiril Retard product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Compared with drugs such as carbamazepine or phenytoin, sodium valproate offers broader spectrum seizure control and mood‑stabilising benefits, but it has a higher risk of liver toxicity and teratogenicity, requiring careful monitoring.

Store tablets below 25 °C in the original container, protecting them from moisture, heat and direct light to maintain stability.

Orfiril Retard is taken orally, usually once daily with food or as directed by a healthcare professional, to maintain consistent plasma concentrations throughout the day.

Serious risks include severe liver injury, pancreatitis, thrombocytopenia, hyperammonemia, and rare skin reactions such as Stevens‑Johnson syndrome, all of which require immediate medical attention.

Patients with known hypersensitivity to sodium valproate, active liver disease, mitochondrial disorders such as POLG‑related disease, or women who are pregnant or may become pregnant should avoid using Orfiril Retard.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.